Tatva Chintan Pharma Chem Limited

Web: tatvachintan.com NSE: TATVA BSE: 543321 SECTOR: Chemicals - Chemicals & Petrochemicals

1719 18(1%)

Near 52W High of 1785

Volume

27k as on 22, Jun

Open

865

High

865

Low

852

1,701

VWAP

1,200

52 Week High

1,785

52 Week Low

927

Viand Research Rating

Quality Score

70/100

Growth Score

77/100

Valuation Score

50/100

Momentum Score

25/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

4,020

No. of Shares

2.34

P/E

151.25

P/B

2.79

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

1.84

ROCE

Profit Growth

Listing Date

29-Jul-21

Promoter Holding

72.02%

FII Holding

3.93%

DII Holding

3.11%

Price Chart

Price Performance

1 Week1%

1 Month0%

3 Months6%

6 Months9%

1 Year9%

YTD9%

Moving Average

5 Day SMA1,192

10 Day SMA1,178

20 Day SMA1,177

30 Day SMA1,205

50 Day SMA1,239

61 Day SMA1,219

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,231	1,201	1,218	1,252
Resistance 2	1,218	1,199	1,209	1,229
Resistance 1	1,206	1,196	1,203	1,227
Pivot Point	1,193	1,194	1,193	1,204
Support 1	1,181	1,192	1,183	1,202
Support 2	1,168	1,189	1,178	1,178
Support 3	1,156	1,187	1,168	1,177

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SOLARINDS	1,67,579	18519	0%	4%	46%	28%	89	57.9	0.24	1737
2	PIDILITIND	1,60,007	1572	0%	1%	8%	9%	62	57.9	0.04	2471
3	SRF	79,131	2670	7%	4%	2%	12%	0	57.9	0.36	1835
4	COROMANDEL	58,502	1983	3%	0%	12%	19%	0	57.9	0.12	1898
5	LINDEINDIA	57,157	6702	5%	6%	15%	4%	0	57.9	0.02	549
6	FACT	52,542	812	3%	10%	3%	16%	0	57.9	2.79	41
7	UPL	50,903	603	2%	1%	14%	17%	0	57.9	0.68	2220
8	FLUOROCHEM	50,532	4600	10%	17%	46%	30%	0	57.9	0.29	574
9	PIIND	41,384	2728	4%	1%	14%	33%	0	57.9	0.03	1321
10	HSCL	39,753	788	6%	19%	77%	58%	0	57.9	0.16	755
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(0.01) 72.02%	(-7.21) 72.02%	(0.01) 79.17%	(0.01) 79.17%	(0.01) 79.17%	(0.01) 79.17%	(0.01) 79.17%	(0.01) 79.17%	(0.01) 79.17%	(0.01) 79.17%
FIIs	(0.11) 3.93%	(-0.41) 3.81%	(0.81) 4.17%	(0.11) 3.40%	(0.01) 3.26%	(-0.11) 3.30%	(0.01) 3.36%	(0.01) 3.33%	(-0.31) 3.37%	(-0.61) 3.65%	(-0.21) 4.21%	(1.21) 4.40%	(-0.41) 3.19%	(-0.21) 3.54%	(0.21) 3.74%	(0.11) 3.59%	(0.51) 3.53%	(0.11) 3.05%	(-0.61) 2.91%	(0.01) 3.53%
DIIs	(0.11) 3.11%	(-0.31) 2.99%	(-0.61) 3.32%	(-1.21) 3.87%	(-0.41) 5.11%	(-0.91) 5.46%	(-0.51) 6.34%	(-3.81) 6.83%	(-2.21) 10.64%	(-0.21) 12.84%	(-0.71) 13.06%	(2.71) 13.78%	(-0.61) 11.07%	(0.21) 11.71%	(0.41) 11.52%	(0.41) 11.17%	(2.61) 10.75%	(0.31) 8.13%	(0.51) 7.87%	(0.01) 7.36%
Public	20.94%	21.16%	20.49%	20.72%	19.60%	19.21%	18.27%	17.81%	13.97%	11.49%	10.72%	9.79%	6.56%	5.59%	5.58%	6.08%	6.55%	9.65%	10.05%	9.94%
No. of Shareholders	64,921	66,842	68,657	73,331	76,792	78,393	79,009	79,623	73,912	73,730	74,519	74,628	70,799	70,037	71,958	76,267	84,358	89,930	88,311	89,438

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	167	134	131	124	117	108	86	83	105	98	84	97	114	125	121	90.09	88.4	98.53	104.67	123.62	106.83
Sales Growth % (YoY)	43%	24.4%	52.9%	48%	10.8%	9.8%	2%	-13.6%	-7.8%	-21.1%	-30.2%	7.3%	29.4%	26.4%	15%	-27.1%	-17.2%	-9.3%	30.6%	105.9%	107.3%
Sales Growth % (QoQ)	24.6%	2.3%	5.6%	6%	8.3%	25.6%	3.6%	-21%	7.1%	16.7%	-13.4%	-14.9%	-8.8%	3.3%	34.3%	1.9%	-10.3%	-5.9%	-15.3%	15.7%	-
Expenses	135	106	106	101	100	99	79	78	93	83	73	76	93	108	103	78.91	73.19	76.54	80.71	88.18	81
Operating Profit	32	28	25	22	17	9	7	6	13	16	11	20	21	16	18	11.18	15.21	21.99	23.96	35.44	25.83
OPM %	19	21	19	18	15	8	8	7	12	16	13	21	19	13	15	12.41	17.21	22.32	22.89	28.67	24.18
Other Income	1	0	2	1	1	1	0	0	1	5	1	1	1	-3	1	1.55	1.88	0.31	4.57	3.25	1.77
Interest	2	1	0	1	0	0	0	0	0	0	0	3	3	3	2	1.36	1.06	1.18	0.99	1.22	1.44
Depreciation	11	10	9	9	9	7	7	7	7	6	7	7	6	3	2	2.31	2.33	2.15	2.08	2.06	1.9
Profit before tax	21	17	18	14	9	2	0	-1	7	14	5	11	13	8	14	9.06	13.7	18.97	25.46	35.41	24.26
Tax %	24	38	14	27	27	49	-165	-34	24	30	34	31	29	-117	18	21.52	28.47	7.75	10.45	8.47	4.58
Net Profit	16	10	15	10	7	1	0	-1	5	10	3	8	10	17	12	7.11	9.8	17.51	22.81	32.41	23.15
Net Profit Growth % (QoQ)	60%	-33.3%	50%	42.9%	600%	100%	100%	-120%	-50%	233.3%	-62.5%	-20%	-41.2%	41.7%	68.8%	-27.4%	-44%	-23.2%	-29.6%	40%	-
Net Profit Growth % (YoY)	128.6%	900%	100%	1100%	40%	-90%	-100%	-112.5%	-50%	-41.2%	-75%	12.5%	2%	-2.9%	-47.4%	-78.1%	-57.7%	-	-	-	-
TTM Net Profit	51	42	33	18	7	5	14	17	26	31	38	47	46.11	45.91	46.42	57.23	82.53	95.88	78.37	55.56	0
EPS in Rs	6.83	4.41	6.49	4.24	2.84	0.44	0.06	-0.28	2.23	4.11	1.48	3.33	4.29	7.65	5.24	3.21	4.42	7.9	10.29	14.62	11.52

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Sales	506	383	394	424	434	300	263	206	136
Sales Growth %	32.2%	-2.7%	-7.1%	-2.3%	44.4%	14.1%	27.6%	51.9%	-
Expenses	413	348	325	363	325	234	208	172	113
Operating Profit	93	35	69	61	109	67	55	34	23
OPM %	18	9	17	14	25	22	21	17	17
Other Income	4	2	7	2	9	5	1	1	1
Interest	3	2	7	9	5	4	4	4	3
Depreciation	37	28	26	10	8	7	5	4	3
Profit before tax	57	8	44	45	104	61	48	27	19
Tax %	26	25	30	-2	8	14	21	25	35
Net Profit	42	6	30	45	96	52	38	21	12
Net Profit Growth %	600%	-80%	-33.3%	-53.1%	84.6%	36.8%	81%	75%	-
EPS in Rs	17.98	2.44	12.97	20.52	43.25	26.02	47.03	25.56	15.3
Dividend Payout %	11	41	15	10	5	19	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Cash from Operating Activity	31	25	98	28	20	20	25	7	13
Cash from Investing Activity	-116	-65	-121	-101	-197	-21	-40	-17	-30
Cash from Financing Activity	79	17	31	38	235	-5	10	17	7
Net Cash Flow	-5	-24	8	-36	59	-6	-5	8	-10

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Equity Capital	23	23	23	23	23	22	22	20	8	8	8
Reserves	758	731	715	714	714	493	451	146	110	72	51
Borrowings	120	83	36	15	14	170	120	90	91	77	56
Other Liabilities	102	70	61	54	67	74	65	59	41	31	28
Total Liabilities	1004	908	836	807	819	759	658	315	249	188	144
Fixed Assets	611	515	526	425	427	196	160	120	111	67	57
CWIP	23	80	27	114	77	231	51	10	5	6	10
Investments	4	0	0	0	10	0	0	0	0	0	1
Other Assets	365	312	283	268	305	332	447	185	133	115	76
Total Assets	1004	908	836	807	819	759	658	315	249	188	144

Delivery

#	Date	1101 62% 1785	Value (Cr)	Q/T 18	Del 40	Del 34
1	24-Jul	1722	27	14	30	8
2	23-Jul	1701	49	14	22	11
3	22-Jul	1665	59	19	26	15
4	21-Jul	1685	285	18	12	33
5	20-Jul	1714	551	29	12	67
6	17-Jul	1428	18	10	45	8
7	16-Jul	1418	6	9	39	2
8	15-Jul	1385	8	10	43	4
9	14-Jul	1412	14	11	42	6
10	13-Jul	1391	21	16	48	10
11	10-Jul	1326	16	11	47	7
12	9-Jul	1239	5	10	55	3
13	8-Jul	1182	6	13	56	3
14	7-Jul	1240	2	8	69	1
15	6-Jul	1255	8	13	54	4
16	3-Jul	1250	2	8	58	1
17	2-Jul	1268	12	11	49	6
18	1-Jul	1189	3	8	53	2
19	30-Jun	1194	4	11	54	2
20	29-Jun	1196	6	12	50	3
21	25-Jun	1181	3	14	57	2
22	24-Jun	1206	5	15	47	2
23	23-Jun	1192	4	11	48	2
24	22-Jun	1191	3	12	55	2
25	19-Jun	1194	2	8	49	1
26	18-Jun	1196	3	7	47	2
27	17-Jun	1194	7	16	52	3
28	16-Jun	1186	3	10	48	1
29	15-Jun	1180	4	11	47	2
30	12-Jun	1208	8	11	47	4
31	11-Jun	1153	4	11	48	2
32	10-Jun	1114	5	12	58	3
33	9-Jun	1160	3	9	45	1
34	8-Jun	1140	2	8	53	1
35	5-Jun	1184	3	7	45	1
36	4-Jun	1191	7	12	43	3
37	3-Jun	1222	5	10	45	2
38	2-Jun	1214	5	9	49	2
39	1-Jun	1196	14	13	35	5
40	29-May	1133	14	14	52	7
41	27-May	1147	5	13	57	3
42	26-May	1158	5	9	53	2
43	25-May	1183	4	8	48	2
44	22-May	1188	4	10	50	2
45	21-May	1188	11	13	57	6
46	20-May	1242	6	12	69	4
47	19-May	1282	7	8	50	3
48	18-May	1252	20	11	31	6
49	15-May	1316	8	10	57	5

Daily Market Cap

Date	Total Market Cap	Change	Chg %
24-Jul	4,020c	39c	0.98
23-Jul	3,982c	94c	2.41
22-Jul	3,888c	63c	1.59
21-Jul	3,951c	606c	18.10
17-Jul	3,345c	23c	0.70
16-Jul	3,322c	2c	0.07
15-Jul	3,319c	49c	1.49
14-Jul	3,270c	16c	0.50
13-Jul	3,254c	267c	8.94
10-Jul	2,987c	88c	3.04
09-Jul	2,899c	132c	4.75
08-Jul	2,768c	134c	4.61
07-Jul	2,901c	34c	1.17
06-Jul	2,936c	129c	4.58
02-Jul	2,807c	34c	1.21
30-Jun	2,773c	22c	0.79
29-Jun	2,796c	47c	1.71
26-Jun	2,749c	40c	1.42
25-Jun	2,788c	31c	1.09
24-Jun	2,819c	44c	1.60
23-Jun	2,774c	2c	0.07
22-Jun	2,772c	23c	0.82
19-Jun	2,795c	3c	0.10
17-Jun	2,793c	23c	0.81
16-Jun	2,770c	27c	0.95
15-Jun	2,797c	24c	0.86
12-Jun	2,821c	179c	6.75
11-Jun	2,643c	0	0

Stock Checklist

Price is above from 52 week high low average: 85%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 10 fund scheme(s) across 4 fund house(s) as of Jul26 · Total value ₹168 Cr · 0 increasing / 6 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Nippon India Mutual Fund	2	0.46%	-	135.5
ICICI Prudential Mutual Fund	4	0.26%	-0.04%	29.6
WhiteOak Capital Mutual Fund	2	0.19%	-0.05%	2.5
Motilal Oswal Mutual Fund	2	0.00%	-	0

Tatva Chintan Pharma Chem Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements